How osteochondritis dissecans came to be understood
Last reviewed November 17, 2026. OwieClear editorial team. Waiting for clinician review. Not medical advice. Talk with your doctor about your own care.
Loose bodies in joints were described long before anyone knew where they came from. The name given to the condition in 1887 proposed a mechanism that turned out to be wrong, and the name stuck anyway.
Almost everything useful about managing it has come from two technologies: the arthroscope and the MRI scanner.
Related pages: Osteochondritis dissecans (loose piece of bone in a joint)
The bottom line
- Loose bodies in joints were described in the 18th century.
- Franz Konig coined the term in 1887, proposing inflammation as the cause.
- The inflammatory explanation was wrong, but the name persists.
- Arthroscopy made staging and minimally invasive treatment possible.
- MRI made stability assessment possible without surgery.
- What actually initiates the lesion.
- Whether the condition has one cause or several.
The story, step by step
What the evidence labels mean
1700s to 1800s
What happens
Observed, unexplained.
What the research shows
- Ambroise Pare described a loose body in a joint in the 16th century, and 18th-century surgeons including John Hunter documented loose bodies and removed some of them.
- The term joint mouse came into use for these fragments, reflecting how they moved around and were hard to catch.
- Where they came from was disputed: theories included fragments of cartilage broken off by injury, growths from the joint lining, and products of inflammation.
- Removing a loose body was one of the few joint operations that reliably helped, and it was performed before anaesthesia and antisepsis, at considerable risk.
- The crater left behind in the joint surface was not generally appreciated, because the inside of the joint could not be inspected without opening it widely.
- James Paget described the process of separation in 1870, calling it quiet necrosis, which was closer to the modern understanding than the name that followed.
Why it matters
Paget's quiet necrosis was a better description than the term that replaced it, which is an occasional pattern in medical naming.
What's still uncertain
- Whether early descriptions were the same condition.
Read more
- NIAMS: Osteochondritis dissecansGovernment
- American Academy of Orthopaedic Surgeons: OrthoInfoNonprofit
Next: The name
1887
What happens
Konig's mistake, preserved.
What the research shows
- Franz Konig, a German surgeon, published in 1887 and coined the term osteochondritis dissecans.
- He proposed that inflammation of bone and cartilage caused the fragment to separate, which is what the name means.
- Subsequent study found little evidence of inflammation, and the primary problem was located in the subchondral bone.
- By then the term was established, and it has persisted for well over a century despite describing the condition inaccurately.
- Konig did correctly separate the condition from loose bodies caused by acute trauma and from other joint diseases, which was the real contribution.
- Panner described the different, younger capitellar condition that bears his name in 1927, which helped clarify what osteochondritis dissecans was not.
Why it matters
The persistence of an inaccurate name is a small reminder that medical terms record the understanding of their time, not the current one.
What's still uncertain
- Why the term was never replaced.
Read more
- NIAMS: Osteochondritis dissecansGovernment
- MedlinePlus: Elbow injuries and disordersGovernment
Next: Seeing inside
1900s to 1980s
What happens
X-rays, then arthroscopy.
What the research shows
- X-rays from 1895 allowed lesions to be seen in living patients for the first time, and the characteristic appearance was described through the early 20th century.
- The limitation was that X-rays showed bone, not cartilage, so stability could not be assessed without opening the joint.
- Arthroscopy, developed through the 20th century and becoming widespread from the 1970s and 1980s, allowed the joint surface to be inspected directly through small incisions.
- That transformed both staging and treatment: lesions could be probed to test stability, loose bodies removed, and drilling performed without opening the joint.
- Arthroscopic classification systems followed, grading lesions by what was seen and felt at surgery.
- Treatment before this was largely open surgery or prolonged immobilisation in plaster, often for many months, with the stiffness and muscle wasting that followed.
Why it matters
Arthroscopy changed this condition from one requiring a major operation to inspect to one that could be assessed and often treated through two small incisions.
What's still uncertain
- How much arthroscopy improved outcomes.
Read more
- American Academy of Orthopaedic Surgeons: OrthoInfoNonprofit
- NIAMS: Osteochondritis dissecansGovernment
Next: MRI and repair
1980s to today
What happens
Staging without surgery, and rebuilding surfaces.
What the research shows
- MRI, becoming widely available from the 1980s, allowed the lesion, the cartilage over it and the interface beneath it to be seen without operating.
- The fluid line behind an unstable fragment became the key sign, and MRI staging systems were developed alongside the arthroscopic ones.
- This changed practice substantially, because the decision between months of rest and an operation could be made from a scan.
- Cartilage repair techniques developed in parallel: microfracture was popularised in the 1980s and 1990s, osteochondral transfer around the same period, and autologous chondrocyte implantation was first reported in 1994.
- Bioabsorbable fixation devices removed the need for a second operation to remove metalwork in many cases.
- The recognition that juvenile and adult lesions behave differently, and that stability is the central question, has shaped modern treatment algorithms.
- What has not changed is the underlying cause, which remains uncertain, and the fact that no technique restores normal cartilage.
Why it matters
Two imaging technologies, rather than any drug or operation, account for most of the improvement in how this condition is managed.
What's still uncertain
- What causes the lesion.
- Whether cartilage can ever be truly restored.